Merck announced on Wednesday, July 1, that it received a Supplementary Statement of Objections (SSO) from the European Commission in the ongoing proceedings concerning the Sigma-Aldrich acquisition, which was completed in 2015.
In July 2017, Merck received a Statement of Objections from the European Commission. This relates to a packaging technology developed by Sigma-Aldrich prior to its acquisition by Merck.
The SSO states that the allegations previously made against Merck will be dropped. The SSO retains allegations made against Sigma-Aldrich, which will be the object of the ongoing proceedings.
Merck stated it is confident that it will be possible to resolve the situation satisfactorily.
Full Content: Nasdaq
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
BHP Unveils £31bn Mining Megamerger Proposal with Anglo American
Apr 25, 2024 by
nhoch@pymnts.com
ByteDance Prefers Shutdown Over Sale of TikTok Amid US Ban Threats
Apr 25, 2024 by
CPI
FCC Votes to Restore Net Neutrality Rules
Apr 25, 2024 by
nhoch@pymnts.com
Apple Rejects Spotify’s Updated App Over In-App Pricing Disclosure
Apr 25, 2024 by
CPI
FCC Set to Reinstate Net Neutrality Rules Today
Apr 25, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI